Outcome | HES (n = 23) | Lactated Ringer’s (n = 22) | Difference | P value |
---|---|---|---|---|
Primary outcome | ||||
Total volume at days 1–3, mL | −1,213 (95% CI −3,975 to 1,549) | 0.39 | ||
Secondary outcomes | ||||
Creatinine at day 1, μmol/L | 77 (66, 99) | 74 (55, 90) | ||
Creatinine at days 1–3, μmol/L | 0.4 (95% CI −18.7 to 19.5) | 0.97 | ||
Urinary output at day 1, mL/d | 1,360 (1,020, 1,770) | 1,430 (970, 2,225) | ||
Urinary output at days 1–3, mL | −58 (95% CI −400 to 283) | 0.90 | ||
Incidence of ARDS | 6 (26.1%) | 6 (27.3%) | ||
Risk ratio for ARDS with HES | 0.96 (95% CI 0.35 to 2.64) | 0.95 | ||
28-day mortality | 4 (17.4%) | 4 (18.2%) | ||
Risk ratio for 28-day mortality with HES | 0.96 (95% CI 0.27 to 4.45) | 0.95 | ||
In hospital mortality | 8 (34.8%) | 5 (22.7%) | ||
Hazard ratio for in-hospital death with HES | 1.86 (95% CI 0.56 to 6.19) | 0.31 | ||
Length of stay in ICU, days | 28 (10, 58) | 24 (11, 49) | 0.80 | |
Length of stay in hospital, days | 31 (18, 58) | 29 (14, 61) | 0.57 |